Merck broke ground on a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Del., the Rahway-based company announced April 29. The Merck Wilmington Biotech ...
The restructuring announcement, anticipated by Wall Street, comes as Merck faces the loss of patent protection for its blockbuster cholesterol drug Zocor -- the world's No. 2 drug by revenues -- next ...
Add Yahoo as a preferred source to see more of our stories on Google. The logo of the pharmaceutical and chemical company Merck is displayed on flags on a building at its headquarters in Darmstadt.